"The Health Tech Investment Act reflects a shift in national health policy toward supporting intelligent, patient- centered innovations," said Mark White, CEO of Nexalin. "Our Gen-3 HALO Clarity™ device exemplifies that approach — combining precision neurostimulation with AI-driven tools that improve care coordination, monitoring, and adherence. This legislation provides a reimbursement path that recognizes and supports this model of care." Proposed bipartisan legislation would expand Medicare reimbursement ...